$OPK
OPKO HEALTH, INC. Stock $opk

$opk Overview Financials Valuation SEC Filings Company Website

2015 Q2 Form 10-Q Financial Statement

#000094480915000011 Filed on August 05, 2015

Income Statement

Concept	2015 Q2	2014 Q2
Revenue	$42.43M	$23.55M
YoY Change	80.2%	-1.16%
Cost Of Revenue	$14.43M	$12.57M
YoY Change	14.87%	-4.11%
Gross Profit	$28.00M	$10.98M
YoY Change	154.96%	-73.74%
Gross Profit Margin	65.98%	46.63%
Selling, General & Admin	$20.94M	$14.87M
YoY Change	40.76%	7.17%
% of Gross Profit	74.79%	135.46%
Research & Development	$29.57M	$16.23M
YoY Change	82.15%	69.87%
% of Gross Profit	105.63%	147.85%
Depreciation & Amortization	$4.152M	$4.027M
YoY Change	3.1%	16.69%
% of Gross Profit	14.83%	36.68%
Operating Expenses	$67.84M	$58.43M
YoY Change	16.1%	39.77%
Operating Profit	-$25.41M	-$34.89M
YoY Change	-27.16%	93.99%
Interest Expense	-$17.50M	$6.300M
YoY Change	-377.78%	-29.21%
% of Operating Profit
Other Income/Expense, Net	-$16.78M	$9.279M
YoY Change	-280.81%	-45.18%
Pretax Income	-$42.19M	-$25.61M
YoY Change	64.75%	2322.52%
Income Tax	$251.0K	$101.0K
% Of Pretax Income
Net Earnings	-$43.24M	-$25.48M
YoY Change	69.71%	650.74%
Net Earnings / Revenue	-101.91%	-108.22%
Basic Earnings Per Share	-$0.09	-$0.06
Diluted Earnings Per Share	-$0.09	-$0.08
COMMON SHARES
Basic Shares Outstanding	462.3M shares	413.8M shares
Diluted Shares Outstanding	462.3M shares

Balance Sheet

Concept	2015 Q2	2014 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$221.2M	$134.0M
YoY Change	65.07%	-20.76%
Cash & Equivalents	$221.2M	$134.0M
Short-Term Investments
Other Short-Term Assets	$3.388M	$2.613M
YoY Change	29.66%	-86.25%
Inventory	$20.52M	$18.33M
Prepaid Expenses
Receivables	$26.98M	$23.11M
Other Receivables	$4.200M	$1.900M
Total Short-Term Assets	$278.3M	$183.0M
YoY Change	52.09%	-20.47%
LONG-TERM ASSETS
Property, Plant & Equipment	$23.41M	$17.35M
YoY Change	34.91%	4.65%
Goodwill	$289.6M	$226.0M
YoY Change	28.14%	175.32%
Intangibles
YoY Change
Long-Term Investments	$11.50M	$27.40M
YoY Change	-58.03%	2.62%
Other Assets	$6.013M	$4.910M
YoY Change	22.46%	76.36%
Total Long-Term Assets	$1.247B	$1.144B
YoY Change	9.01%	178.39%
TOTAL ASSETS
Total Short-Term Assets	$278.3M	$183.0M
Total Long-Term Assets	$1.247B	$1.144B
Total Assets	$1.525B	$1.327B
YoY Change	14.95%	107.01%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$16.04M	$10.04M
YoY Change	59.74%	-13.78%
Accrued Expenses	$149.8M	$54.96M
YoY Change	172.62%	77.05%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due	$14.60M	$14.40M
YoY Change	1.4%	-14.19%
Total Short-Term Liabilities	$180.5M	$79.40M
YoY Change	127.3%	33.52%
LONG-TERM LIABILITIES
Long-Term Debt	$2.148M	$2.948M
YoY Change	-27.14%	-98.44%
Other Long-Term Liabilities	$408.8M	$218.5M
YoY Change	87.11%	171.07%
Total Long-Term Liabilities	$518.0M	$334.9M
YoY Change	54.7%	24.42%
TOTAL LIABILITIES
Total Short-Term Liabilities	$180.5M	$79.40M
Total Long-Term Liabilities	$518.0M	$334.9M
Total Liabilities	$698.5M	$414.3M
YoY Change	68.62%	26.07%
SHAREHOLDERS EQUITY
Retained Earnings	-$834.7M	-$573.2M
YoY Change	45.62%	34.44%
Common Stock	$4.646M	$4.271M
YoY Change	8.78%	25.95%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$3.645M	$4.051M
YoY Change	-10.02%	-45.68%
Treasury Stock Shares	1.120M shares	1.245M shares
Shareholders Equity	$834.8M	$917.4M
YoY Change
Total Liabilities & Shareholders Equity	$1.525B	$1.327B
YoY Change	14.95%	107.01%

Cashflow Statement

Concept	2015 Q2	2014 Q2
OPERATING ACTIVITIES
Net Income	-$43.24M	-$25.48M
YoY Change	69.71%	650.74%
Depreciation, Depletion And Amortization	$4.152M	$4.027M
YoY Change	3.1%	16.69%
Cash From Operating Activities	-$34.10M	-$21.90M
YoY Change	55.71%	265.0%
INVESTING ACTIVITIES
Capital Expenditures	-$1.000M	-$1.600M
YoY Change	-37.5%	23.08%
Acquisitions
YoY Change
Other Investing Activities	-$97.00M	-$1.500M
YoY Change	6366.67%	-97.11%
Cash From Investing Activities	-$98.10M	-$3.000M
YoY Change	3170.0%	-94.36%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	4.700M	2.500M
YoY Change	88.0%	-175.76%
NET CHANGE
Cash From Operating Activities	-34.10M	-21.90M
Cash From Investing Activities	-98.10M	-3.000M
Cash From Financing Activities	4.700M	2.500M
Net Change In Cash	-127.5M	-22.40M
YoY Change	469.2%	-64.16%
FREE CASH FLOW
Cash From Operating Activities	-$34.10M	-$21.90M
Capital Expenditures	-$1.000M	-$1.600M
Free Cash Flow	-$33.10M	-$20.30M
YoY Change	63.05%	331.91%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2015
	dei	Document Period End Date DocumentPeriodEndDate	2015-06-30
	dei	Document Type DocumentType	10-Q
	dei	Entity Central Index Key EntityCentralIndexKey	0000944809
CY2015Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	463617245	shares
	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
	dei	Entity Registrant Name EntityRegistrantName	Opko Health, Inc.
CY2014Q4	opk	Accrued Clinical Trials Current AccruedClinicalTrialsCurrent	8643000	USD
CY2015Q2	opk	Accrued Clinical Trials Current AccruedClinicalTrialsCurrent	8534000	USD
CY2014Q4	opk	Availablefor Sale Securities Accumulated Gross Realized Gain Loss Net AvailableforSaleSecuritiesAccumulatedGrossRealizedGainLossNet	-3232000	USD
CY2015Q2	opk	Availablefor Sale Securities Accumulated Gross Realized Gain Loss Net AvailableforSaleSecuritiesAccumulatedGrossRealizedGainLossNet	-4602000	USD
	opk	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration If Discount Rates Increase One Percent BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationIfDiscountRatesIncreaseOnePercent	-1200000	USD
	opk	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration If Estimated Future Sales Decrease Ten Percent BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationIfEstimatedFutureSalesDecreaseTenPercent	-1700000	USD
CY2014Q4	opk	Business Combination Recognized Identifiable Assets Acquiredand Liabilities Assumed Goodwilland Intangible Assets BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedGoodwillandIntangibleAssets	1100000000	USD
CY2015Q2	opk	Business Combination Recognized Identifiable Assets Acquiredand Liabilities Assumed Goodwilland Intangible Assets BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedGoodwillandIntangibleAssets	1200000000	USD
CY2014Q2	opk	Collaborative Arrangement Grant Repayment CollaborativeArrangementGrantRepayment	0	USD
	opk	Collaborative Arrangement Grant Repayment CollaborativeArrangementGrantRepayment	0	USD
CY2015Q1	opk	Collaborative Arrangement Grant Repayment CollaborativeArrangementGrantRepayment	25900000	USD
CY2015Q2	opk	Collaborative Arrangement Grant Repayment CollaborativeArrangementGrantRepayment	0	USD
	opk	Collaborative Arrangement Grant Repayment CollaborativeArrangementGrantRepayment	25889000	USD
	opk	Common Stock Warrants Net Exercised CommonStockWarrantsNetExercised	3493000	USD
	opk	Common Stock Warrants Net Exercised CommonStockWarrantsNetExercised	14239000	USD
CY2014Q4	opk	Debt Instruments Numberof Financial Institutions DebtInstrumentsNumberofFinancialInstitutions	12	institution
CY2015Q2	opk	Debt Instruments Numberof Financial Institutions DebtInstrumentsNumberofFinancialInstitutions	8	institution
CY2015Q2	opk	Equity Method Investment Excluding Variable Interest Entity EquityMethodInvestmentExcludingVariableInterestEntity	6746000	USD
CY2015Q2	opk	Equity Method Investment Variable Interest Entity EquityMethodInvestmentVariableInterestEntity	903000	USD
CY2014Q2	opk	Income Lossfrom Continuing Operations Before Investmentsin Investees Extraordinary Items Noncontrolling Interest Netof Tax IncomeLossfromContinuingOperationsBeforeInvestmentsinInvesteesExtraordinaryItemsNoncontrollingInterestNetofTax	-25707000	USD
	opk	Income Lossfrom Continuing Operations Before Investmentsin Investees Extraordinary Items Noncontrolling Interest Netof Tax IncomeLossfromContinuingOperationsBeforeInvestmentsinInvesteesExtraordinaryItemsNoncontrollingInterestNetofTax	-68737000	USD
CY2015Q2	opk	Income Lossfrom Continuing Operations Before Investmentsin Investees Extraordinary Items Noncontrolling Interest Netof Tax IncomeLossfromContinuingOperationsBeforeInvestmentsinInvesteesExtraordinaryItemsNoncontrollingInterestNetofTax	-42437000	USD
	opk	Income Lossfrom Continuing Operations Before Investmentsin Investees Extraordinary Items Noncontrolling Interest Netof Tax IncomeLossfromContinuingOperationsBeforeInvestmentsinInvesteesExtraordinaryItemsNoncontrollingInterestNetofTax	-158713000	USD
CY2014Q2	opk	Interest Expense Nonoperating InterestExpenseNonoperating	4685000	USD
	opk	Interest Expense Nonoperating InterestExpenseNonoperating	8171000	USD
CY2015Q2	opk	Interest Expense Nonoperating InterestExpenseNonoperating	986000	USD
	opk	Interest Expense Nonoperating InterestExpenseNonoperating	3551000	USD
CY2014Q2	opk	Interest Income Nonoperating InterestIncomeNonoperating	7000	USD
	opk	Interest Income Nonoperating InterestIncomeNonoperating	48000	USD
CY2015Q2	opk	Interest Income Nonoperating InterestIncomeNonoperating	5000	USD
	opk	Interest Income Nonoperating InterestIncomeNonoperating	12000	USD
CY2012Q3	opk	Numberof Medicare Claims Includedin Post Payment Review Audit NumberofMedicareClaimsIncludedinPostPaymentReviewAudit	183	claim
	opk	Ownership Percentageby Shareholder OwnershipPercentagebyShareholder	0.684
	opk	Percentage Of Increase Decrease In Discount Rate PercentageOfIncreaseDecreaseInDiscountRate	0.01
CY2015Q2	opk	Percentage Of Increase Decrease In Future Sales PercentageOfIncreaseDecreaseInFutureSales	0.1
	opk	Revenue From Receipt Of Equity RevenueFromReceiptOfEquity	120000	USD
	opk	Revenue From Receipt Of Equity RevenueFromReceiptOfEquity	120000	USD
CY2014Q2	opk	Revenue From Transfer Of Intellectual Property RevenueFromTransferOfIntellectualProperty	0	USD
	opk	Revenue From Transfer Of Intellectual Property RevenueFromTransferOfIntellectualProperty	476000	USD
CY2015Q2	opk	Revenue From Transfer Of Intellectual Property RevenueFromTransferOfIntellectualProperty	17673000	USD
	opk	Revenue From Transfer Of Intellectual Property RevenueFromTransferOfIntellectualProperty	30202000	USD
CY2015Q2	opk	Shares Surrendered In Lieu Of Cash Payment SharesSurrenderedInLieuOfCashPayment	45	shares
	opk	Shares Surrendered In Lieu Of Cash Payment SharesSurrenderedInLieuOfCashPayment	1206654	shares
CY2015Q2	opk	Stock Issued During Period Shares Stock Optionsand Warrants Exercised StockIssuedDuringPeriodSharesStockOptionsandWarrantsExercised	2106679	shares
	opk	Stock Issued During Period Shares Stock Optionsand Warrants Exercised StockIssuedDuringPeriodSharesStockOptionsandWarrantsExercised	24168461	shares
CY2015Q2	opk	Stock Issued During Period Shares Stock Optionsand Warrants Exercised Netof Shares Surrenderedin Lieuof Cash Payment StockIssuedDuringPeriodSharesStockOptionsandWarrantsExercisedNetofSharesSurrenderedinLieuofCashPayment	2106634	shares
	opk	Stock Issued During Period Shares Stock Optionsand Warrants Exercised Netof Shares Surrenderedin Lieuof Cash Payment StockIssuedDuringPeriodSharesStockOptionsandWarrantsExercisedNetofSharesSurrenderedinLieuofCashPayment	22635661	shares
CY2015Q2	opk	Stock Optionand Warrant Investments StockOptionandWarrantInvestments	9969000	USD
CY2014Q4	opk	Taxes Recoverable Current TaxesRecoverableCurrent	2417000	USD
CY2015Q2	opk	Taxes Recoverable Current TaxesRecoverableCurrent	3074000	USD
CY2014Q4	us-gaap	Accounts And Other Receivables Net Current AccountsAndOtherReceivablesNetCurrent	669000	USD
CY2015Q2	us-gaap	Accounts And Other Receivables Net Current AccountsAndOtherReceivablesNetCurrent	1107000	USD
CY2014Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	8744000	USD
CY2015Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	16039000	USD
CY2014Q4	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	21875000	USD
CY2015Q2	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	29045000	USD
CY2014Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	19969000	USD
CY2015Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	26980000	USD
CY2014Q4	us-gaap	Accrued Employee Benefits Current AccruedEmployeeBenefitsCurrent	4127000	USD
CY2015Q2	us-gaap	Accrued Employee Benefits Current AccruedEmployeeBenefitsCurrent	5456000	USD
CY2014Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	77000	USD
CY2015Q2	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	2592000	USD
CY2014Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	60912000	USD
CY2015Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	149843000	USD
CY2014Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	1860000	USD
CY2015Q2	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	1724000	USD
CY2014Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-12392000	USD
CY2015Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-18880000	USD
CY2014Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	1529096000	USD
CY2015Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	1687389000	USD
CY2014Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	1906000	USD
CY2015Q2	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	2065000	USD
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	1807000	USD
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	895000	USD
CY2014Q2	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	2826000	USD
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	5569000	USD
CY2015Q2	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	3236000	USD
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	5901000	USD
CY2014Q4	us-gaap	Assets Assets	1267664000	USD
CY2015Q2	us-gaap	Assets Assets	1525491000	USD
CY2014Q4	us-gaap	Assets Current AssetsCurrent	142869000	USD
CY2015Q2	us-gaap	Assets Current AssetsCurrent	278339000	USD
CY2014Q4	us-gaap	Available For Sale Securities AvailableForSaleSecurities	12072000	USD
CY2015Q2	us-gaap	Available For Sale Securities AvailableForSaleSecurities	13785000	USD
CY2014Q4	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	509000	USD
CY2015Q2	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	898000	USD
CY2014Q4	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	4573000	USD
CY2015Q2	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	7119000	USD
CY2014Q4	us-gaap	Available For Sale Securities Amortized Cost AvailableForSaleSecuritiesAmortizedCost	12904000	USD
CY2015Q2	us-gaap	Available For Sale Securities Amortized Cost AvailableForSaleSecuritiesAmortizedCost	15404000	USD
CY2015Q2	us-gaap	Available For Sale Securities Noncurrent AvailableForSaleSecuritiesNoncurrent	3816000	USD
CY2014Q2	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	1876000	USD
	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	4486000	USD
CY2015Q2	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	-339000	USD
	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	4836000	USD
CY2014Q4	us-gaap	Business Combination Contingent Consideration Liability BusinessCombinationContingentConsiderationLiability	71600000	USD
CY2015Q2	us-gaap	Business Combination Contingent Consideration Liability BusinessCombinationContingentConsiderationLiability	74300000	USD
CY2014Q4	us-gaap	Business Combination Contingent Consideration Liability Current BusinessCombinationContingentConsiderationLiabilityCurrent	27352000	USD
CY2015Q2	us-gaap	Business Combination Contingent Consideration Liability Current BusinessCombinationContingentConsiderationLiabilityCurrent	41146000	USD
CY2013Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	185798000	USD
CY2014Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	134010000	USD
CY2014Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	96907000	USD
CY2015Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	221217000	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-51788000	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	124310000	USD
CY2014Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2015Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2014Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	750000000	shares
CY2015Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	750000000	shares
CY2014Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	433421677	shares
CY2015Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	464567632	shares
CY2014Q4	us-gaap	Common Stock Value CommonStockValue	4334000	USD
CY2015Q2	us-gaap	Common Stock Value CommonStockValue	4646000	USD
CY2014Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-26575000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-73140000	USD
CY2015Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-44142000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-166366000	USD
CY2014Q2	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-597000	USD
	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-1137000	USD
CY2015Q2	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-475000	USD
	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-1400000	USD
CY2014Q2	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-27172000	USD
	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-74277000	USD
CY2015Q2	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-44617000	USD
	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-167766000	USD
CY2014Q4	us-gaap	Convertible Long Term Notes Payable ConvertibleLongTermNotesPayable	131454000	USD
CY2015Q2	us-gaap	Convertible Long Term Notes Payable ConvertibleLongTermNotesPayable	109203000	USD
CY2014Q2	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	12565000	USD
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	24955000	USD
CY2015Q2	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	14434000	USD
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	24755000	USD
CY2014Q4	us-gaap	Deferred Revenue DeferredRevenue	6700000	USD
CY2015Q2	us-gaap	Deferred Revenue DeferredRevenue	272400000	USD
CY2014Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	4185000	USD
CY2015Q2	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	75159000	USD
CY2014Q4	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	2526000	USD
CY2015Q2	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	197279000	USD
CY2014Q4	us-gaap	Deferred Tax Liabilities Noncurrent DeferredTaxLiabilitiesNoncurrent	167153000	USD
CY2015Q2	us-gaap	Deferred Tax Liabilities Noncurrent DeferredTaxLiabilitiesNoncurrent	172458000	USD
CY2014Q2	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	4027000	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	7591000	USD
CY2015Q2	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	4152000	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	7685000	USD
CY2014Q2	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.06
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.17
CY2015Q2	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.09
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.35
	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	85000	USD
	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	-452000	USD
	us-gaap	Embedded Derivative Gain Loss On Embedded Derivative Net EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet	68000000	USD
CY2015Q2	us-gaap	Equity Method Investment Quoted Market Value EquityMethodInvestmentQuotedMarketValue	88100000	USD
CY2015Q2	us-gaap	Equity Method Investment Summarized Financial Information Assets EquityMethodInvestmentSummarizedFinancialInformationAssets	403200000	USD
CY2015Q2	us-gaap	Equity Method Investment Summarized Financial Information Liabilities EquityMethodInvestmentSummarizedFinancialInformationLiabilities	96700000	USD
	us-gaap	Equity Method Investment Summarized Financial Information Net Income Loss EquityMethodInvestmentSummarizedFinancialInformationNetIncomeLoss	-52500000	USD
CY2015Q2	us-gaap	Equity Method Investment Underlying Equity In Net Assets EquityMethodInvestmentUnderlyingEquityInNetAssets	23735000	USD
CY2014Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	33931000	USD
CY2015Q2	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	38798000	USD
CY2014Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	62649000	USD
CY2015Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	94247000	USD
	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	824000	USD
	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-300000	USD
CY2014Q2	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	10967000	USD
	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	594000	USD
CY2015Q2	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	-16556000	USD
	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	-66344000	USD
CY2014Q2	us-gaap	Gain Loss On Investments GainLossOnInvestments	-370000	USD
	us-gaap	Gain Loss On Investments GainLossOnInvestments	-2426000	USD
CY2015Q2	us-gaap	Gain Loss On Investments GainLossOnInvestments	-804000	USD
	us-gaap	Gain Loss On Investments GainLossOnInvestments	-2565000	USD
	us-gaap	Gain Loss On Sale Of Investments GainLossOnSaleOfInvestments	1274000	USD
	us-gaap	Gain Loss On Sale Of Investments GainLossOnSaleOfInvestments	216000	USD
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	2668000	USD
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-291000	USD
CY2014Q4	us-gaap	Goodwill Goodwill	224292000	USD
CY2015Q2	us-gaap	Goodwill Goodwill	289607000	USD
	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	66823000	USD
	us-gaap	Goodwill Other Changes GoodwillOtherChanges	-1508000	USD
CY2014Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-25606000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-68023000	USD
CY2015Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-42186000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-152953000	USD
CY2014Q2	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-370000	USD
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-2426000	USD
CY2015Q2	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-804000	USD
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-2565000	USD
CY2014Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	101000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	714000	USD
CY2015Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	251000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	5760000	USD
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	796000	USD
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	757000	USD
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-3308000	USD
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	7101000	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	4321000	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	4812000	USD
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-2817000	USD
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	2741000	USD
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-846000	USD
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	263926000	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	1413000	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	3257000	USD
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-3911000	USD
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	512000	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-3466000	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-1142000	USD
CY2014Q4	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	793152000	USD
CY2015Q2	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	812446000	USD
	us-gaap	Interest Paid InterestPaid	2771000	USD
	us-gaap	Interest Paid InterestPaid	1724000	USD
CY2014Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	12116000	USD
CY2015Q2	us-gaap	Inventory Finished Goods InventoryFinishedGoods	13830000	USD
CY2014Q4	us-gaap	Inventory Net InventoryNet	16604000	USD
CY2015Q2	us-gaap	Inventory Net InventoryNet	20519000	USD
CY2014Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	4116000	USD
CY2015Q2	us-gaap	Inventory Raw Materials InventoryRawMaterials	5782000	USD
CY2014Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	639000	USD
CY2015Q2	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	712000	USD
CY2014Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	1011000	USD
CY2015Q2	us-gaap	Inventory Work In Process InventoryWorkInProcess	1619000	USD
	us-gaap	Inventory Write Down InventoryWriteDown	583000	USD
	us-gaap	Inventory Write Down InventoryWriteDown	710000	USD
CY2014Q4	us-gaap	Liabilities Liabilities	431923000	USD
CY2015Q2	us-gaap	Liabilities Liabilities	698505000	USD
CY2014Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1267664000	USD
CY2015Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1525491000	USD
CY2014Q4	us-gaap	Liabilities Current LiabilitiesCurrent	83111000	USD
CY2015Q2	us-gaap	Liabilities Current LiabilitiesCurrent	180481000	USD
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	626000	USD
CY2014Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	348812000	USD
CY2015Q2	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	518024000	USD
CY2015Q2	us-gaap	Line Of Credit Facility Maximum Borrowing Capacity LineOfCreditFacilityMaximumBorrowingCapacity	13867000	USD
CY2014Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	13455000	USD
CY2015Q2	us-gaap	Long Term Debt Current LongTermDebtCurrent	14599000	USD
CY2014Q4	us-gaap	Line Of Credit LineOfCredit	7658000	USD
CY2015Q2	us-gaap	Line Of Credit LineOfCredit	8358000	USD
CY2014Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	2434000	USD
CY2015Q2	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	2148000	USD
CY2014Q4	us-gaap	Long Term Investments LongTermInvestments	22453000	USD
CY2015Q2	us-gaap	Long Term Investments LongTermInvestments	21434000	USD
CY2014Q4	us-gaap	Minority Interest MinorityInterest	-6403000	USD
CY2015Q2	us-gaap	Minority Interest MinorityInterest	-7803000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-4001000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	18482000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-3331000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-98458000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-44541000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	204738000	USD
CY2014Q2	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-597000	USD
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-1137000	USD
CY2015Q2	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-475000	USD
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-1400000	USD
CY2014Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-25480000	USD
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-70026000	USD
CY2015Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-42766000	USD
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-159878000	USD
CY2014Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	9279000	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-2863000	USD
CY2015Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-16777000	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-70631000	USD
	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	2	Segment
CY2014Q2	us-gaap	Operating Expenses OperatingExpenses	58430000	USD
	us-gaap	Operating Expenses OperatingExpenses	110978000	USD
CY2015Q2	us-gaap	Operating Expenses OperatingExpenses	67838000	USD
	us-gaap	Operating Expenses OperatingExpenses	154835000	USD
CY2014Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-34885000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-65160000	USD
CY2015Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-25409000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-82322000	USD
CY2014Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	14668000	USD
CY2015Q2	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	15232000	USD
CY2014Q4	us-gaap	Other Assets Current OtherAssetsCurrent	4212000	USD
CY2015Q2	us-gaap	Other Assets Current OtherAssetsCurrent	3388000	USD
CY2014Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	5838000	USD
CY2015Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	6013000	USD
	us-gaap	Other Comprehensive Income Loss Before Reclassifications Net Of Tax OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax	-6488000	USD
CY2014Q2	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	188000	USD
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-1613000	USD
	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax	553000	USD
CY2015Q2	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax	0	USD
CY2015Q2	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-694000	USD
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-4547000	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-6488000	USD
CY2014Q2	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax	0	USD
	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax	0	USD
CY2014Q2	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-1283000	USD
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-948000	USD
CY2015Q2	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-682000	USD
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-1941000	USD
CY2014Q4	us-gaap	Other Liabilities And Deferred Revenue Noncurrent OtherLiabilitiesAndDeferredRevenueNoncurrent	1030000	USD
CY2015Q2	us-gaap	Other Liabilities And Deferred Revenue Noncurrent OtherLiabilitiesAndDeferredRevenueNoncurrent	3753000	USD
CY2014Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	217358000	USD
CY2015Q2	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	408821000	USD
CY2014Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	2990000	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	4666000	USD
CY2015Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	760000	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-748000	USD
	us-gaap	Other Significant Noncash Transaction Value Of Consideration Received1 OtherSignificantNoncashTransactionValueOfConsiderationReceived1	6264000	USD
	us-gaap	Other Significant Noncash Transaction Value Of Consideration Received1 OtherSignificantNoncashTransactionValueOfConsiderationReceived1	0	USD
	us-gaap	Paid In Kind Interest PaidInKindInterest	3557000	USD
	us-gaap	Paid In Kind Interest PaidInKindInterest	1681000	USD
	us-gaap	Payments For Previous Acquisition PaymentsForPreviousAcquisition	6435000	USD
	us-gaap	Payments For Previous Acquisition PaymentsForPreviousAcquisition	0	USD
	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	-1331000	USD
	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	0	USD
	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	1695000	USD
	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	94674000	USD
	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	500000	USD
	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	2345000	USD
	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	2467000	USD
	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	1439000	USD
CY2014Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	9389000	USD
CY2015Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	9623000	USD
CY2014Q4	us-gaap	Prepaid Insurance PrepaidInsurance	968000	USD
CY2015Q2	us-gaap	Prepaid Insurance PrepaidInsurance	613000	USD
	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	2747000	USD
	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	17366000	USD
	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	14258000	USD
	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	11038000	USD
	us-gaap	Proceeds From Payments To Minority Shareholders ProceedsFromPaymentsToMinorityShareholders	0	USD
	us-gaap	Proceeds From Payments To Minority Shareholders ProceedsFromPaymentsToMinorityShareholders	100000	USD
CY2014Q2	us-gaap	Profit Loss ProfitLoss	-26077000	USD
	us-gaap	Profit Loss ProfitLoss	-71163000	USD
CY2015Q2	us-gaap	Profit Loss ProfitLoss	-43241000	USD
	us-gaap	Profit Loss ProfitLoss	-161278000	USD
CY2014Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	16411000	USD
CY2015Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	23405000	USD
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	-68000	USD
CY2015Q2	us-gaap	Purchase Obligation PurchaseObligation	19200000	USD
	us-gaap	Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax	0	USD
	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	14571000	USD
	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	10022000	USD
CY2014Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	16234000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	37227000	USD
CY2015Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	29570000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	55072000	USD
CY2014Q2	us-gaap	Research And Development In Process ResearchAndDevelopmentInProcess	10055000	USD
	us-gaap	Research And Development In Process ResearchAndDevelopmentInProcess	10055000	USD
CY2015Q2	us-gaap	Research And Development In Process ResearchAndDevelopmentInProcess	0	USD
	us-gaap	Research And Development In Process ResearchAndDevelopmentInProcess	0	USD
CY2014Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-674843000	USD
CY2015Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-834721000	USD
CY2014Q2	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	21392000	USD
	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	41219000	USD
CY2015Q2	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	22848000	USD
	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	38334000	USD
CY2014Q2	us-gaap	Sales Revenue Net SalesRevenueNet	23545000	USD
	us-gaap	Sales Revenue Net SalesRevenueNet	45818000	USD
CY2015Q2	us-gaap	Sales Revenue Net SalesRevenueNet	42429000	USD
	us-gaap	Sales Revenue Net SalesRevenueNet	72513000	USD
CY2014Q2	us-gaap	Sales Revenue Services Net SalesRevenueServicesNet	2153000	USD
	us-gaap	Sales Revenue Services Net SalesRevenueServicesNet	4123000	USD
CY2015Q2	us-gaap	Sales Revenue Services Net SalesRevenueServicesNet	1908000	USD
	us-gaap	Sales Revenue Services Net SalesRevenueServicesNet	3977000	USD
CY2014Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	14874000	USD
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	28686000	USD
CY2015Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	20937000	USD
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	38382000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	6993000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	14090000	USD
CY2014Q4	us-gaap	Stockholders Equity StockholdersEquity	842144000	USD
CY2015Q2	us-gaap	Stockholders Equity StockholdersEquity	834789000	USD
CY2014Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	835741000	USD
CY2015Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	826986000	USD
CY2014Q4	us-gaap	Supplies Supplies	1123000	USD
CY2015Q2	us-gaap	Supplies Supplies	1441000	USD
CY2014Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	1245367	shares
CY2015Q2	us-gaap	Treasury Stock Shares TreasuryStockShares	1120367	shares
CY2014Q4	us-gaap	Treasury Stock Value TreasuryStockValue	4051000	USD
CY2015Q2	us-gaap	Treasury Stock Value TreasuryStockValue	3645000	USD
	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Expense UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense	2300000	USD
CY2014Q4	us-gaap	Variable Interest Entity Consolidated Carrying Amount Assets VariableInterestEntityConsolidatedCarryingAmountAssets	7600000	USD
CY2015Q2	us-gaap	Variable Interest Entity Consolidated Carrying Amount Assets VariableInterestEntityConsolidatedCarryingAmountAssets	7100000	USD
CY2014Q4	us-gaap	Variable Interest Entity Consolidated Carrying Amount Liabilities VariableInterestEntityConsolidatedCarryingAmountLiabilities	12100000	USD
CY2015Q2	us-gaap	Variable Interest Entity Consolidated Carrying Amount Liabilities VariableInterestEntityConsolidatedCarryingAmountLiabilities	12700000	USD
CY2014Q2	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	413339679	shares
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	413125932	shares
CY2015Q2	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	462253161	shares
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	454361137	shares
	us-gaap	Use Of Estimates UseOfEstimates	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Use of estimates</font><font style="font-family:inherit;font-size:10pt;">. The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ significantly from these estimates.</font></div></div>

Files In Submission

Name	View Source	Status
0000944809-15-000011-index-headers.html	Edgar Link	pending
0000944809-15-000011-index.html	Edgar Link	pending
0000944809-15-000011.txt	Edgar Link	pending
0000944809-15-000011-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
horizonsparedacted21image1.jpg	Edgar Link	pending
opk-20150630.xml	Edgar Link	completed
opk-20150630.xsd	Edgar Link	pending
opk-20150630_cal.xml	Edgar Link	unprocessable
opk-20150630_def.xml	Edgar Link	unprocessable
opk-20150630_lab.xml	Edgar Link	unprocessable
opk-20150630_pre.xml	Edgar Link	unprocessable
opk-6302015x10q.htm	Edgar Link	pending
opk-6302015xex21.htm	Edgar Link	pending
opk-6302015xex22.htm	Edgar Link	pending
opk-6302015xex311.htm	Edgar Link	pending
opk-6302015xex312.htm	Edgar Link	pending
opk-6302015xex321.htm	Edgar Link	pending
opk-6302015xex322.htm	Edgar Link	pending
opkoformsparedacted22_image1.jpg	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$OPK
OPKO HEALTH, INC. Stock $opk

2015 Q2 Form 10-Q Financial Statement

#000094480915000011 Filed on August 05, 2015

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$OPK OPKO HEALTH, INC. Stock $opk

2015 Q2 Form 10-Q Financial Statement

#000094480915000011 Filed on August 05, 2015

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$OPK
OPKO HEALTH, INC. Stock $opk